AP1AR
AP-1 complex-associated regulatory protein
Also known as: 2C18, AP1AR_HUMAN, C4orf16, gamma-BAR, PRO0971
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q63HQ0
- Gene
- AP1AR
- Ensembl
- ENSG00000138660
- Chromosome
- 4
- Canonical length
- 302 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Enables AP-1 adaptor complex binding activity and kinesin binding activity. Involved in negative regulation of receptor recycling and vesicle targeting, trans-Golgi to endosome. Acts upstream of or within negative regulation of substrate adhesion-dependent cell spreading. Located in Golgi apparatus and transport vesicle. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
302 residues, UniProt reviewed canonical sequence.
>Q63HQ0|AP1AR
1 MGNCCWTQCF GLLRKEAGRL QRVGGGGGSK YFRTCSRGEH LTIEFENLVE SDEGESPGSS
61 HRPLTEEEIV DLRERHYDSI AEKQKDLDKK IQKELALQEE KLRLEEEALY AAQREAARAA
121 KQRKLLEQER QRIVQQYHPS NNGEYQSSGP EDDFESCLRN MKSQYEVFRS SRLSSDATVL
181 TPNTESSCDL MTKTKSTSGN DDSTSLDLEW EDEEGMNRML PMRERSKTEE DILRAALKYS
241 NKKTGSNPTS ASDDSNGLEW ENDFVSAEMD DNGNSEYSGF VNPVLELSDS GIRHSDTDQQ
301 TRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AP1AR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 39 nTPM
- small intestine: 22 nTPM
- duodenum: 21 nTPM
- kidney: 21 nTPM
- liver: 19 nTPM
- colon: 17 nTPM
Single-cell type
- early spermatids: 121 nCPM
- late spermatids: 94 nCPM
- salivary acinar cells: 86 nCPM
- smooth muscle cells: 83 nCPM
- urothelial cells: 79 nCPM
- enterocytes: 74 nCPM
Immune cell
- intermediate monocyte: 10 nTPM
- myeloid DC: 9.5 nTPM
- NK-cell: 9 nTPM
- naive CD8 T-cell: 8.9 nTPM
- naive CD4 T-cell: 8.5 nTPM
- non-classical monocyte: 8.5 nTPM
Brain region
- cerebellum: 18 nTPM
- cerebral cortex: 16 nTPM
- hippocampal formation: 16 nTPM
- hypothalamus: 16 nTPM
- white matter: 14 nTPM
- basal ganglia: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cell motility
- negative regulation of receptor recycling
- negative regulation of substrate adhesion-dependent cell spreading
- protein transport
- regulation of Arp2/3 complex-mediated actin nucleation
- substrate adhesion-dependent cell spreading
- vesicle targeting, trans-Golgi to endosome
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- AP-1 complex-associated regulatory protein
- AP-1 complex-associated regulatory protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AP1AR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AP1AR as an antibody target. Whether an autoantibody or antibody against AP1AR could matter depends on whether native AP1AR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AP1AR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AP1AR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...